The place of combining ischemia modified albumin (IMA) levels to myocardial perfusion scintigraphy (MPS) in diagnosis of coronary artery disease

Basit Öğe Kaydı
dc.contributor.authorKoc, Z. P.
dc.contributor.authorBasaraci, I.
dc.contributor.authorDeger, N.
dc.contributor.authorSaka, O.
dc.contributor.authorErkilic, M.
dc.date.accessioned2026-08-12T18:13:16Z
dc.date.issued2009
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpageS314
dc.identifier.issn1619-7070
dc.identifier.startpageS314
dc.identifier.urihttps://hdl.handle.net/11508/64313
dc.identifier.volume36
dc.identifier.wosWOS:000208690801268
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imaging
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleThe place of combining ischemia modified albumin (IMA) levels to myocardial perfusion scintigraphy (MPS) in diagnosis of coronary artery disease
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu